obuprazine   Click here for help

GtoPdb Ligand ID: 14737

Synonyms: example 12A [WO2022228447] [1] | HS-10380 | TRTL-107
Compound class: Synthetic organic
Comment: Obuprazine (TRTL-107, HS-10380) is an orally bioavailable dopamine D2/D3 partial agonist and 5-HT2A antagonist. The structure shown here has the stereochemistry as defined by the IUPAC descriptor in the INN record.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 57.17
Molecular weight 423.34
XLogP 2.46
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=CC(=C(C(=C1)Cl)Cl)N2CCN(CC[C@H]3C[C@@H](C3)NC(=O)C4=NC=CO4)CC2
Isomeric SMILES ClC1=C(C=CC=C1Cl)N2CCN(CC2)CC[C@@H]3C[C@H](C3)NC(=O)C=4OC=CN4
InChI InChI=1S/C20H24Cl2N4O2/c21-16-2-1-3-17(18(16)22)26-9-7-25(8-10-26)6-4-14-12-15(13-14)24-19(27)20-23-5-11-28-20/h1-3,5,11,14-15H,4,6-10,12-13H2,(H,24,27)/t14-,15-
InChI Key VSYIBUZNSGDCAN-SHTZXODSSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
Obuprazine (as HS-10380) was progressed as a clinical candidate to evaluate it as a potential schizophrenia therapeutic.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT07550387 A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia Phase 2 Interventional Jiangsu Hansoh Pharmaceutical Co., Ltd.
NCT07759869 A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia Phase 3 Interventional Jiangsu Hansoh Pharmaceutical Co., Ltd.